Study of First Affordable and Rapid Test for Beta Thalassemia Performs at 99% Accuracy in Diagnosing the Blood Disorder A clinical study demonstrated high accuracy for Hemex Health's beta thalassemia test. It is the only beta thal test for point of care.

PositiveID’s ExcitePCR Subsidiary CEO to Speak on National Academies of Science, Engineering, and Medicine Panel Today DELRAY BEACH, Fla., Sept. 18, 2017 (GLOBE NEWSWIRE) -- September 18, 2017 – PositiveID Corporation's (OTCQB:PSID) ExcitePCR subsidiary’s President, CEO, and Founder, Lyle L. Probst, will be featured...

PositiveID Reports Revenue of $4.6 Million for First Nine Months of 2016, Up 70% from $2.7 Million for First Nine Months of 2015 DELRAY BEACH, Fla., Nov. 21, 2016 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a life sciences company focused on detection and diagnostics, has announced...

PositiveID to Exhibit at the Biodefense World Summit June 27-29 Company to feature its molecular diagnostics and mobile labs businesses DELRAY BEACH, Fla., June 15, 2016 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a...

PositiveID Announces First Firefly Dx Testing and Delivery of Positive PCR Results Within 20 Minutes DELRAY BEACH, Fla., March 12, 2015 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCQB:PSID), a developer of biological detection and diagnostics solutions, today announced...